About Index Trending news
Analyze
Top 50 Pricing
Rigontec GmbH

Rigontec GmbH

Work at Rigontec GmbH? Add yourself to this profile

Elsewhere

Alexa global traffic share

Latest funding
Venture capital (Series A)
€15,000,000
Sunstone Capital, MP Healthcare Venture Management, NRW.BANK, +3
Employees

Unknown size

Locations
HQ
Headquarters
rigontec

Rigontec GmbH – A Dual Approach To Treat Cancer is a privately held biopharmaceutical company that develops RNA-based immunotherapeutics for the treatment of cancer and viral diseases.

Health Science Funding
€15,000,000 Venture capital (Series A)
FinSMEs

Rigontec Raises €15M in Third Closing of Series A Funding

Funding Health